This week’s signal. This week’s pick. What to do with both.
Photo by National Cancer Institute on Unsplash
Last month, my model picked a stock most people wouldn’t have guessed — a name still living down its association with a pandemic that’s mostly behind us, weeks removed from a headline-grabbing 160% single-session spike and an equally sharp round-trip lower.
I bought it anyway. Not because of the headline. Because the rank said to.
Since that Monday, the position is up 7% — and this month, the same name is back on the list, and higher up it.
QuantRanks runs once a month. It doesn’t carry a memory of what it bought the cycle before, and it doesn’t check whether last month’s picks are already working. It just scores all 450+ stocks fresh against this month’s data. This name landed near the top again anyway.
Signal: BUY.
Capital stays invested — core and pick both.
Subscribe for free to see this week’s pick — the name, the numbers, and why the rank found it twice.
Expect Earning forecast upwards for the up coming period, eventhogh past pe ratio is negative